1.Lautenbach, E, Polk, RE. Resistant gram-negative bacilli: a neglected healthcare crisis? Am J Health Syst Pharm 2007;64:S3–S21.
2.Bantar, C, Sartori, B, Vesco, E, et al. A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 2003;37:180–186.
3.Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140.
4.Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial susceptibility Testing: 18th Informational Supplement. Wayne, PA: CLSI, 2008. CLSI document. M100-S18.
5.Efron, B, Tibshirani, RJ. An Introduction to the Bootstrap. London: Chapman & Hall, 1993.
6.Rattanaumpawan, P, Tolomeo, P, Bilker, WB, Fishman, NO, Lautenbach, E. Risk factors for fluoroquinolone resistance in gram-negative bacilli causing healthcare-acquired urinary tract infections. J Hosp Infect 2010;76:324–327.
7.Dellit, TH, Owens, RC, McGowan, JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44: 159–177.